Compare VTSI & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTSI | NOTV |
|---|---|---|
| Founded | 1993 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 29.9M |
| IPO Year | N/A | 1997 |
| Metric | VTSI | NOTV |
|---|---|---|
| Price | $4.78 | $0.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $7.00 | $3.00 |
| AVG Volume (30 Days) | 53.9K | ★ 1.6M |
| Earning Date | 11-10-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $24,934,267.00 | ★ $513,024,000.00 |
| Revenue This Year | N/A | $6.26 |
| Revenue Next Year | $13.39 | $45.49 |
| P/E Ratio | $326.68 | ★ N/A |
| Revenue Growth | N/A | ★ 4.54 |
| 52 Week Low | $3.57 | $0.66 |
| 52 Week High | $7.49 | $6.48 |
| Indicator | VTSI | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 35.16 |
| Support Level | $4.79 | $0.79 |
| Resistance Level | $5.13 | $0.86 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 7.55 | 3.93 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.